Tuesday, May 26, 2020

Qualigen In Reverse Merger, Raises $4M In Private Placement

Carlsbad-base Qualigen, a developer of products for the treatment of cancer and infectious diseases, said this morning that it has completed its merger with publicly traded Ritter Pharmaceuticals (RTTR). The companies said the newly merged company will operate under the name Qualigen Therapeutics, Inc., and the newly merged company will begin trading on the Nasdaq Capital Market today under

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.